Get in Touch
0
0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Clinical Diagnostics
ctDNA MRD and Monitoring Front and Center at ASCO 2022
ctDNA MRD and monitoring was front and center at ASCO 2022. We analyzed 19 abstracts published by leading commercial players.
August 2, 2022
Blog Article
Clinical Diagnostics
ctDNA MRD and Monitoring Front and Center at ASCO 2022
ctDNA MRD and monitoring was front and center at ASCO 2022. We analyzed 19 abstracts published by leading commercial players.
August 2, 2022
Research Tools
Diagnostics Market
Liquid Biopsy
Precision Medicine
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | July Roundup
July stands out for its wealth of news on company growth - read about some of the many financing rounds, acquisitions, and partnerships the next-gen space saw in the last month.
July 29, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | July Roundup
July stands out for its wealth of news on company growth - read about some of the many financing rounds, acquisitions, and partnerships the next-gen space saw in the last month.
July 29, 2022
Next-Generation Therapeutics
DeciBio Q&A
Pharma & Biotech
mIF Landscape and COMET Launch: DeciBio’s Q&A with Déborah Heintze of Lunaphore
Our Q&A with co-founder and CMO at Lunaphore, Déborah Heintze, dives into the spatial biology market today and covers key details on Lunaphore’s new COMET platform.
July 27, 2022
DeciBio Q&A
Pharma & Biotech
mIF Landscape and COMET Launch: DeciBio’s Q&A with Déborah Heintze of Lunaphore
Our Q&A with co-founder and CMO at Lunaphore, Déborah Heintze, dives into the spatial biology market today and covers key details on Lunaphore’s new COMET platform.
July 27, 2022
Diagnostics Market
Immuno-Oncology
Proteomics Market
Clinical Diagnostics
Biomarkers
DeciBio News
Financial Services
DeciBio Ventures Invests in Replay’s $55M seed funding round led by KKR & Co. and OMX Ventures
DeciBio Ventures invested in the seed funding round for Replay. KKR & Co. Inc. and OMX Ventures led this funding round, which totaled $55 million.
July 25, 2022
DeciBio News
Financial Services
DeciBio Ventures Invests in Replay’s $55M seed funding round led by KKR & Co. and OMX Ventures
DeciBio Ventures invested in the seed funding round for Replay. KKR & Co. Inc. and OMX Ventures led this funding round, which totaled $55 million.
July 25, 2022
DeciBio News
DeciBio Ventures
Cell & Gene Tx
Blog Article
Clinical Diagnostics
Introduction to MtDNA: A Burgeoning Biomarker in Cancer
With the rapid growth of liquid biopsy research, biomarkers like mtDNA, in addition to more “traditional” analytes (e.g., ctDNA, cfDNA, proteins), are being pursued.
July 15, 2022
Blog Article
Clinical Diagnostics
Introduction to MtDNA: A Burgeoning Biomarker in Cancer
With the rapid growth of liquid biopsy research, biomarkers like mtDNA, in addition to more “traditional” analytes (e.g., ctDNA, cfDNA, proteins), are being pursued.
July 15, 2022
Liquid Biopsy
Genomics Market
Clinical Diagnostics
Biomarkers
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | June Roundup
Liquid Biopsy (LBx) in June was spearheaded by novel company partnerships and product launches as well as clinical trial launches and validation study result updates.
July 11, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | June Roundup
Liquid Biopsy (LBx) in June was spearheaded by novel company partnerships and product launches as well as clinical trial launches and validation study result updates.
July 11, 2022
Liquid Biopsy
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions